Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Drugs Made In America Acquisition II Corp./ 10-Q

Quarterly Report · 10-Q

Drugs Made In America Acquisition II Corp.

DMIINASDAQEQUITYCurrent

Quarterly Report

Filed Aug 14, 2026Accepted Aug 14, 2026, 4:05 PM EDTCIK 2040475Accession 0001213900-26-090017
View company →Permanent SEC source ↗
Share

Company context

Current securities

DMIINASDAQ · EQUITY · CurrentDMIIRNASDAQ · RIGHT · CurrentDMIIUNASDAQ · UNIT · Current

Recent company filings

  1. 10-Q filingMay 14, 2026
  2. Entry into a Material Definitive AgreementApr 28, 2026
  3. 10-K filingApr 15, 2026
  4. Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementApr 3, 2026
  5. NT 10-K filingApr 1, 2026

Registered securities in this filing

DRUGS MADE IN AMERICA ACQUISITION II CORP. · 10-Q · Filed 2026-08-14

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Units, each consisting of one Ordinary Share, par value $0.0001 per share, and one Right to receive one-tenth (1/10) of an Ordinary Share

Symbol
DMIIU
Exchange
NASDAQ
Classification
UNIT
Status
Current
Filing context

Context: cref_1793761353

Dimensions: us-gaap:StatementClassOfStockAxis

Ordinary Shares

Symbol
DMII
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: cref_2145160126

Dimensions: us-gaap:StatementClassOfStockAxis

Rights

Symbol
DMIIR
Exchange
NASDAQ
Classification
RIGHT
Status
Current
Filing context

Context: cref_1228544849

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000121390026090017 · 3 registered-security cover members

Read the exact SEC filing ↗

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.